Psychedelic Medicine: Research, Regulations, & the Future of Psilocybin- and MDMA-Assisted Therapy

 
When:
Location:
Online
Room:
Zoom
https://bit.ly/3s3lcX9
 
Description:

As research continues to demonstrate that psychedelic drugs can have potential benefits in a therapeutic setting, attention has now turned towards the training of therapists who will administer such therapies once they are fully approved by the FDA. Currently, The University of Baltimore is exploring a possible training partnership with the Multidisciplinary Association for Psychedelic Studies (MAPS). This symposium will feature a series of guest lectures on current research and approaches to therapy from experts in the field of psychedelic medicine.

GUEST SPEAKERS

  • Rick Doblin, Ph.D., founder and executive director of the Multidisciplinary Association for Psychedelic Studies
     
  • Matthew W. Johnson, Ph.D., professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine
     
  • Jospeh McCowan, Psy.D., licensed clinical psychologist and psychotherapist

REGISTER HERE

Contact Name:
Michael Frederick
Contact Email:
mfrederick@ubalt.edu

Appropriate accommodations for individuals with disabilities will be provided upon request 10 days prior to a campus event and 30 days prior to an event requiring travel.

Add to calendar